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Introduction: In an upright posture, central venous pressure (CVP)
becomes negative, in parallel with reduction in the central blood
volume and, consequently, preload to the heart and cardiac output
(CO) decreases (Harms et al. 2003). The influence of orthostatic
reduction in CVP on preload to the heart is not established. During
exercise leg muscles pump blood from the legs towards the heart
(Beecher et al. 1936) as illustrated by enhanced plasma ANP,
apparently with little influence on CVP (Vogelsang et al. 2006). We
hypothesized that even though orthostasis reduces CVP also during
exercise, the increased cardiac preload brings about an increase in
CO.
Aim: This study evaluated the effect of the presumed different central
venous pressure (CVP) response to running and rowing on preload to
the heart. Preload was indicated by distension of the atrium as
evaluated by plasma arterial natriuretic peptide (ANP) and related to
cardiac output (CO).
Conclusion: During exercise the increase in CO is curvilinearly
related to plasma ANP, as an indication of preload to the heart, but it is 
unrelated to CVP. The results indicate that in the upright posture CVP 
reflects the gravitational influence on central venous blood and not 
preload to the heart.
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Results: While sitting CO was 6.2 ± 1.6 l/min, plasma ANP 70 ± 10
pg/ml, and CVP 1.8 ± 1.1mmHg (mean ± SD) and decreased to 5.9 ±
1.0 l/min, 63 ± 10 pg/ml, and -3.8 ± 1.2 mmHg when standing (P <
0.05). Ergometer rowing elicited an increase in CO to 22.5 ± 5.5 l/min
as plasma ANP increased to 156 ± 11 pg/ml and CVP to 3.8 ± 0.9
mmHg (P < 0.05). Similarly, CO increased to 23.5 ± 6.0 l/min during
running with albeit smaller (P < 0.05) increase in plasma ANP, but with
little change in CVP (around -0.9 ± 0.4 mmHg)
Methods: Seven healthy subjects (four men; 26 ± 3 years; 181± 8 cm
height; and 76 ± 11 kg, weight; mean ± SD) performed, in random
order, rowing on an ergometer (Concept II, Morrisville, VT, USA) and
walking followed by running on a treadmill (Runrace, Technogym,
Gambettola, Italy) at three intensities aiming at heart rate (HR) of 120,
140, and 160 beats per minute and lasting about 7 min each.
Cardiovascular variables
CVP was measured from a catheter advanced to the right atrium and
mean arterial pressure (MAP) was determined from the radial artery.
A modified Modelflow method estimated CO from the radial arterial
pressure (Finapres Medical Systems, Amsterdam, the Netherlands).
HR was recorded from a three-lead electrocardiogram (Medicotest Q-
10-A, Copenhagen, Denmark).
Blood samples from the radial artery and the central venous catheter
were analyzed for pH, oxygen saturation (SO2) and tension (PO2)
(ABL, Radiometer, Copenhagen, Denmark). Also, arterial samples (in
EDTA tubes) were analyzed for ANP by radioimmunoassay (Schütten
et al. 1987).
Figures. Logarithmic and linear regressions between cardiac output 
(CO), plasma atrial natriuretic peptide (ANP, left) and central venous 
pressure (CVP, above) at rest and during three exercise intensities for 
running and rowing (n = 7, P < 0.05). 
